American College of Neuropsychopharmacology (2004). Executive Summary. Preliminary Report of Task Force on SSRIs and Suicidal Behaviour in Youth. Retrieved January 11, 2005 from http://www.acnp.org/exec_summary.pdfGoogle Scholar

BBC News (2003). Panorama: Seroxat: E-mails from the edge. Retrieved January 11, 2005 from http://news.bbc.co.uk/l/hi/programmes/panorama/2982797.stmGoogle Scholar

Brent, D.A. & Birmaher, B. (2004). British warnings on SSRIs questioned. Journal American Academy of Child and Adolescent Psychiatry 43, 379–380.Google Scholar

Carlsten, A., Waern, M., Ekedahl, A. & Ranstam, J. (2001). Antidepressant medication and suicide in Sweden. Phannacoepidemiology and Drug Safety 10, 525–530.Google Scholar

Committee on Safety of Medicines (2003). Selective Serotonin Reuptake inhibitors (SSRIs) - overview of regulatory status and CSM advice relating to major depressive disorder (MDD) in children and adolescents: summary of clinical trials. London: Committee on Safety of Medicines. Retrieved January 12, 2005 from http://medicines.mhra.gov.uk/ourwork/monitorsafequalmed/safetymessages/SSRIfinal.pdfGoogle Scholar

Compton, S.N., March, J.S., Brent, D., Albano, A.M., Weersing, V.R. & Curry, J. (2004). Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents: an evidence-based medicine review. Journal of the American Academy of Child and Adolescent Psychiatry 43, 930–959.CrossRefGoogle Scholar

Emslie, G.J., Rush, A.J., Weinberg, W.A., Kowatch, R.A., Hughes, C.W., Carmody, T. & Rintelmann, J. (1997). A double-blind, randomised, placebo-controlled trial of Fluoxetine in children and adolescents with depression. Archives of General Psychiatry 54, 1031–1037.Google Scholar

Emslie, G.J., Heiligenstein, J.H., Wagner, K.D., Hoog, S.L., Ernest, D.E., Brown, E., Nilsson, M. & Jacobson, J.G. (2002). Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial. American Academy of Child and Adolescent Psychiatry 41,1205–1215.Google Scholar

Fergusson, D.M. & Woodward, L.J. (2002). Mental health, educational, and social role outcomes of adolescents with depression. Archives of General Psychiatry 59, 225–231.Google Scholar

Garland, E.J. (2004). Facing the evidence: antidepressant treatment in children and adolescents. Canadian Medical Association 170, 489–1345.Google Scholar

Gray, D., Moskos, M. & Keller, T. (2003). Utah Youth Suicide Study New Findings. Presented at the Annual Meeting of the American Association of Suicidology, Sante Fe, New Mexico.Google Scholar

Gunnell, D. & Ashby, D. (2004). Antidepressants and suicide: what is the balance of benefit and harm. British Medical Journal 329(7456), 34–38.CrossRefGoogle Scholar

Harrington, R., Whittaker, J., Shoebridge, P. & Campbell, F. (1998). Systematic review of efficacy of cognitive behaviour therapies in childhood and adolescent depressive disorder. British Medical Journal 316,1559–1563.CrossRefGoogle Scholar

Hawton, K., Rodham, K., Evans, E. & Weatherall, R. (2002). Deliberate self harm in adolescents: self report survey in schools in England. British Medical Journal 325,1207–1211.Google Scholar

Hawton, K., Hall, S., Simkin, S., Bale, L., Bond, A., Codd, S. & Stewart, A. (2003). Deliberate self-harm in adolescents: a study of characteristics and trends in Oxford, 1900-2000. Journal of Child Psychology and Psychiatry 44, 1191–1198.Google Scholar

Hazell, P., O'Connell, D., Heathcote, D., Robertson, J. & Henry, D. (1995). Efficacy of tricyclics drugs in treating child and adolescent depression: a meta-analysis. British Medical Journal 310, 897–901.Google Scholar

Hazell, P., O'Connell, D., Heathcote, D. & Henry, D. (2002). Tricyclic drugs for depression in children and adolescents. Cochrane Database of Systematic Reviews, Issue 2.Google Scholar

Healy, D. 2003). Lines of evidence on the risks of suicide with selective serotonin reuptake inhibitors. Psychotherapy and Psychosomatics 72, 71–79.Google Scholar

Isacsson, G. (2000). Suicide prevention-a medical breakthrough? Acta Psychiatrica Scandanavica 102, 113–117.Google Scholar

Isacsson, G., Holmgren, P., Druid, H. & Bergman, U. (1997). The utilisation of antidepressants - a key issue in the prevention of suicide: an anlysis of 5281 suicides in Sweden during the period 1992-1994. Acta Psychiatrica Scandanavica 96, 94–100.Google Scholar

Jick, H., Kaye, J.A. & Jick, S.S. (2004). Antidepressants and the risk of suicidal behaviours. Journal of the American Medical Association 292, 338–343.Google Scholar

Jureidini, J.N., Doecke, C.J., Mansfield, P.R., Haby, M.M., Menkes, D.B. & Tonkin, A.L. (2004). Efficacy and safety of antidepressants for children and adolescents. British Medical Journal 328, 879–883.Google Scholar

Keller, M.B., Ryan, N.D., Strober, M., Klein, R.G., Kutcher, S.P., Birmaher, B., Hagino, O.R., Koplewicz, H., Carlson, G.A., Clarke, G.N., Emslie, G.J., Feinberg, D., Geller, B., Kusumakar, V., Papatheodorou, G., Sack, W.H., Sweeney, M., Wagner, K.D., Weller, E.B., Winters, N.C., Oakes, R. & McCafferty, J.P. (2001). Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry 40, 762–772.Google Scholar

Khan, A., Khan, S., Kolts, R. & Brown, W.A. (2003). Suicide rates in clinical trial of SSRIs, other antidepressants, and placebo: analysis of FDA reports. American Journal of Psychiatry 160, 90–792.CrossRefGoogle Scholar

Mandoki, M.W., Tapia, M.R., Tapia, M.A., Sumner, G.S. & Parker, J.L. (1997). Venlafaxine in the treatment of children and adolescents with major depression. Psychophannacology Bulletin 33, 149–154.Google Scholar

McClure, M. (2001). Suicide in children and adolescents in England and Wales 1970-1998. British Medical Journal 178, 469–474.Google Scholar

Mufson, L., Dorta, P., Wickramaratne, P., Nomura, Y., Olfson, M. & Weissman, M.M. (2004). A randomized effectiveness trial of inter-personal psychotherapy for depressed adolescents. Archives of General Psychiatry 61, 577–584.Google Scholar

Nutt, D.J. (2003). Death and dependence: current controversies over the selective serotonin Psxchopharmacology 17, 355–364.Google Scholar

Ohberg, A., Vuori, E., Klaukka, T. & Lonnqvist, J. (1998). Antidepressants and suicide mortality Journal of Affective Disorders 50, 225–233.Google Scholar

Olfson, M., Shaffer, D., Marcus, S.C. & Greenberg, T. (2003). Relationship between antidepressant medication treatment and suicide in adolescents. Archives of General Psychiatry 60, 978–982.Google Scholar

Pich, J., Came, X., Arnaiz, J.A., Gomez, B., Trilla, A. & Rodes, J. (2003). Role of a research ethics committee in follow-up and publication of results. Lancet 361, 1015–1016.Google Scholar

Poznanski, E.O. & Mokros, H.B. (1996). Manual: Children's Depression Rating Scale-Revised. Western Psychological Services: Los Angeles.Google Scholar

Poznanski, E.O., Cook, S.C. & Carroll, B.J. (1979). A depression rating scale for children. Pediatrics 64, 442–450.Google Scholar

Ramchandani, P. (2004'). Treatment of major depressive disorder in children and adolescents: most selective serotonin reuptake inhibitors are no longer recommended. British Medical Journal 328, 518–520.Google Scholar

Ramchandani, P. (2004b). A question of balance: how safe are the medicines that are prescribed to children? Nature 430, 401–402.Google Scholar

Rao, U., Weissman, M.M., Martin, J.A. & Hammond, R.W. (1993). Childhood depression and risk of suicide: preliminary report of a longitudinal study. Journal of the American Academy of Child and Adolescent Psychiatry 32, 21–27.Google Scholar

Simeon, J.G., Dinicola, V.F., Fergusson, H.B. & Copping, W. (1990). Adolescent depression: a placebo-controlled fluoxetine treatment study and follow-up. Progress in Neuro-Psychopharmacology & Biological Psychiatry 14, 791–795.Google Scholar

Treatment for Adolescents With Depression Study Team (2004). Fluoxetine, cognitive-behavioral therapy, and their contribution for adolescent with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. Journal of American Medical Association 292, 807–820.Google Scholar

US Food and Drugs Administration (2004). FDA Statement on Recommendations of the Psychopharmacologic Drugs and Pediatric Advisory Committee. Retrieved January 11, 2005 from http://www.fda.gov/bbs/topics/news/2004/NEW01116.htmlGoogle Scholar

Wagner, K. D., Ambrosini, P., Rynn, M., Wohlberg, C, Yang, R., Greenbaum, M.S., Childress, A., Donnelly, C. & Deas, D. (2003). Sertraline Pediatric Depression Study GroupEfficacy of sertraline in the treatment of children and adolescents with major depressive dis-order. Journal of the American Medical Association 290, 1033–1041.Google Scholar

Wagner, K.D., Robb, A.S., Findling, R.L., Jin, J., Gutierrez, M.M. & Heydorn, W.E. (2004). A randomised, placebo-controlled Trial of citalopram for the treatment of major depression in children and adolescents. American Journal Psychiatry 161, 1079–1083.Google Scholar

Wessely, S. & Kerwin, R. (2004). Suicide risk and the SSRIs. Journal of the American Medical Association 292, 379–381.Google Scholar

World Health Organisation (2003). Suicide Prevention and special programmes. Country reports and charts available. Retrieved January 11, 2005 from http://www.who.int/mentaUiealth/prevention/suicide/country_reports/en/Google Scholar

Whittington, C.J., Kendall, T., Fonagy, P., Cottrell, D., Cotgrove, A. & Boddington, E. (2004). Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 363, 341–1345.Google Scholar